BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26458430)

  • 1. [Diagnosis and management of pure red cell aplasia].
    Hirokawa M
    Rinsho Ketsueki; 2015 Oct; 56(10):1922-31. PubMed ID: 26458430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the clinical management of pure red cell aplasia and future prospects].
    Hirokawa M
    Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of pure red cell aplasia].
    Fujishima N
    Rinsho Ketsueki; 2021; 62(8):931-937. PubMed ID: 34497233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
    Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
    Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in the diagnosis and management of acquired pure red cell aplasia].
    Ishida F
    Rinsho Ketsueki; 2020; 61(9):1098-1104. PubMed ID: 33162504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia-associated pure red cell aplasia.
    D'Arena G; Cascavilla N
    Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of acquired pure red cell aplasia.
    Sawada K; Hirokawa M; Fujishima N
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):249-59. PubMed ID: 19327582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red cell aplasia: The second hundred years.
    Means RT
    Am J Med Sci; 2023 Sep; 366(3):160-166. PubMed ID: 37327996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible complications of erythropoietin therapy in patients with chronic renal failure].
    Pljesa S
    Med Pregl; 2004; 57(5-6):254-7. PubMed ID: 15503795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure red cell aplasia--a rare disease with multiple causes.
    Djaldetti M; Blay A; Bergman M; Salman H; Bessler H
    Biomed Pharmacother; 2003 Oct; 57(8):326-32. PubMed ID: 14568226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.
    Vlachaki E; Diamantidis MD; Klonizakis P; Haralambidou-Vranitsa S; Ioannidou-Papagiannaki E; Klonizakis I
    ScientificWorldJournal; 2012; 2012():475313. PubMed ID: 22593689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.
    Hirokawa M; Fukuda T; Ohashi K; Hidaka M; Ichinohe T; Iwato K; Kanamori H; Murata M; Sakura T; Imamura M; Adachi S; Suzuki R; Morishima Y; Sakamaki H;
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1026-32. PubMed ID: 23583828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pure red cell aplasia: Diagnosis, classification and treatment].
    Lobbes H
    Rev Med Interne; 2023 Jan; 44(1):19-26. PubMed ID: 36336519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red cell aplasia.
    Means RT
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):51-56. PubMed ID: 27913462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome.
    Choudry MA; Moffett BK; Laber DA
    Ann Hematol; 2007 Apr; 86(4):233-7. PubMed ID: 17262194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired pure red cell aplasia: updated review of treatment.
    Sawada K; Fujishima N; Hirokawa M
    Br J Haematol; 2008 Aug; 142(4):505-14. PubMed ID: 18510682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure Red Cell Aplasia Caused by Azathioprine.
    Kounatidis D; Vallianou N; Daskalaki V; Masaoutis C; Margellou E; Harhalakis N; Kokkinakis E
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):164-165. PubMed ID: 30156166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult pure red cell aplasia at Universitas Academic Hospital, Bloemfontein, South Africa: A 9-year review.
    Thibile S; Barrett C; Potgieter S; Joubert G; Malherbe J
    S Afr Med J; 2022 Aug; 112(9):753-759. PubMed ID: 36214038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.